The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of… (NCT07000409) | Clinical Trial Compass
RecruitingNot Applicable
The Effectiveness of Ultra-Sound Guided Erector Spinae Block With Betamethasone for Management of Truncal Chronic Post Herpetic Neuralgia.
Egypt40 participantsStarted 2025-05-01
Plain-language summary
To investigate the effectiveness of ultra-Sound guided Erector spinae block (ESB) with Betamethasone as an adjuvant to standard medical protocol in the management of truncal chronic post herpetic neuralgia.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients age between 18 and 75.
* Patients with American Society of Anesthesiologists (ASA) II and III status.
* Patients diagnosed with truncal chronic post herpetic neuralgia( neuropathic pain persistent for more than 3 months from the onset of rash appearance )
Exclusion Criteria:
* Patients unable to comprehend the informed consent.
* Patients on long term opioid regimens.
* Patients with impairment in hepatic (Alanine aminotransferase (ALT) \>50 U/L, and/or Aspartate aminotransferase (AST): \>45 U/L) or renal functions( creatinine level ≥1.5 mg/dL)
* Patients on anti-coagulation regimens.
* Patients with coagulation abnormalities (i.e. international normalized ratio (INR) ≥1.5 and/or platelets ≤50000)
* Local infection in the site of the block.
* Patients with body mass index (BMI) \> 35.